Still, the relatively robust connection between AR CAGn and disease susceptibility and the high occurrence of the disease in men (approximately 16% lifetime risk; Altekruse et al. 1975), coupled with successful reproduction to relatively old ages in human men, mean that even modest increases in the susceptibility to prostate cancer could engender considerable fitness costs and be an important contributor to AR CAGn polymorphism frequencies in contemporary human populations. The gene discussed is AR; the disease is Familial prostate cancer.